EUVIMEDEUVIMED entdecken
Crossref

Discovery of Quinazoline and Quinoline-Based Small Molecules as Utrophin Upregulators via AhR Antagonism for the Treatment of Duchenne Muscular Dystrophy

Surojit Ghosh, Mohammad Umar Arshi, Satyajit Ghosh, Moumita Jash, Samya Sen, Kamel Mamchaoui, Sudipta Bhattacharyya, Nirmal Kumar Rana iD, Surajit Ghosh iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Surojit Ghosh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Smart Healthcare Department, Interdisciplinary Research Platform, Indian Institute of Technology, Jodhpur, Rajasthan 342030, India. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Utrophin, Quinolines, Receptors, Aryl Hydrocarbon. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Science and Engineering Research Board, Indian Institute of Technology Jodhpur, Ministry of Education, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disease caused by the absence of a dystrophin protein. Elevating utrophin, a dystrophin paralogue, offers an alternative therapeutic strategy for treating DMD, irrespective of the mutation type. Herein, we report the design and synthesis of novel quinazoline and quinoline-based small molecules as potent utrophin modulators screened via high throughput In-Cell ELISA in C2C12 cells. Remarkably, lead molecule SG-02, identified from a library of 70 molecules, upregulates utrophin 2.7-fold at 800 nM in a dose-dependent manner, marking the highest upregulation within the nanomolar range. SG-02's efficacy was further validated through DMD patient-derived cells, demonstrating a significant 2.3-fold utrophin expression. Mechanistically, SG-02 functions as an AhR antagonist, with excellent binding affinity (Kd = 41.68 nM). SG-02 also enhances myogenesis, as indicated by an increased MyHC expression. ADME evaluation supports SG-02's oral bioavailability. Overall, SG-02 holds promise for addressing the global DMD population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneUtrophinQuinolinesReceptors, Aryl HydrocarbonQuinazolinesHumansAnimalsMiceSmall Molecule LibrariesDrug DiscoveryUp-RegulationCell LineStructure-Activity RelationshipBasic Helix-Loop-Helix Proteins

Substanzen

UtrophinQuinolinesReceptors, Aryl HydrocarbonQuinazolinesSmall Molecule LibrariesBasic Helix-Loop-Helix ProteinsAHR protein, humanquinoline

Autor:innen und Institutionen

  • Smart Healthcare Department, Interdisciplinary Research Platform, Indian Institute of Technology, Jodhpur, Rajasthan 342030, India.
  • Department of Bioscience and Bioengineering, Indian Institute of Technology, Jodhpur, Rajasthan 342030, India.
  • Inserm, Institut de Myologie, Centre de Recherche en Myologie,Sorbonne Université, F-75013 Paris, France.
  • Department of Chemistry, Indian Institute of Technology, Jodhpur, Rajasthan 342030, India.

ORCID-Profile: Nirmal Kumar Rana, Surajit Ghosh

Förderung

  • Science and Engineering Research Board
  • Indian Institute of Technology Jodhpur
  • Ministry of Education, India

Zitieren

APA

Ghosh, S., Arshi, M. U., Ghosh, S., Jash, M., Sen, S., Mamchaoui, K., Bhattacharyya, S., Rana, N. K., & Ghosh, S. (2024). Discovery of Quinazoline and Quinoline-Based Small Molecules as Utrophin Upregulators via AhR Antagonism for the Treatment of Duchenne Muscular Dystrophy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00398

Vancouver

Ghosh S, Arshi MU, Ghosh S, Jash M, Sen S, Mamchaoui K, et al. Discovery of Quinazoline and Quinoline-Based Small Molecules as Utrophin Upregulators via AhR Antagonism for the Treatment of Duchenne Muscular Dystrophy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00398

BibTeX
@article{Ghosh2024,
  author = {Ghosh, Surojit and Arshi, Mohammad Umar and Ghosh, Satyajit and Jash, Moumita and Sen, Samya and Mamchaoui, Kamel and Bhattacharyya, Sudipta and Rana, Nirmal Kumar and Ghosh, Surajit},
  title = {Discovery of Quinazoline and Quinoline-Based Small Molecules as Utrophin Upregulators via AhR Antagonism for the Treatment of Duchenne Muscular Dystrophy},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00398}
}
Kostenlos starten →